Shares jumped over 8% after the company reported an 86% YoY surge in Q3FY26 net profit, driven by strong revenue growth, ...
Clean Science witnessed a decline across all parameters — net profit, revenue and earning before interest, tax, depreciation ...
Strides Pharma Science surged 8.91% to Rs 881.05 after reporting a margin-driven performance for Q3 FY26, even as topline growth remained modest.
Strides Pharma Science Ltd (BOM:532531) reports robust financial performance with improved margins and successful geographical diversification, despite challenges in the US market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results